Insider Holders & Insider Ownership - MEDICINOVA INC (MNOV)

List of insiders holdings for MEDICINOVA INC:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
Kiyoizumi Takashi
President and CEO
2005-01-28 21:42:046,678,286
0
6,678,286Form 3
3D Investment Partners Pte. Ltd.
3D Opportunity Master Fund
10% Owner
2022-07-12 12:12:025,502,047
0
5,502,047Form 13D
Nakata Kousuke
Director
2014-01-15 18:02:500
3,000,000
3,000,000Form 3
Satomi Hajime
10% Owner
2018-05-16 19:50:032,217,000
0
2,217,000Form 13G
BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BIOTECHNOLOGY VALUE FUND II LP
BVF INVESTMENTS LLC
BVF INC
LAMPERT MARK N
10% Owner
2009-12-24 16:04:331,455,610
0
1,455,610Form 13G
Kissei Pharmaceutical Co. Ltd.
10% Owner
2017-06-14 16:05:331,400,000
0
1,400,000Form 13D
ESSEX WOODLANDS HEALTH VENTURES FUND VI L P
10% Owner
2016-02-12 13:03:001,210,370
0
1,210,370Form 13D
Okajima Masatsune
VP and Head of Japanese Office
2019-03-04 06:00:231,040,530
0
1,040,530Form 4
Izumi Tatsuo
Director
2013-12-13 16:06:36600,000
158,730
758,730Form 4
Tanabe Holding America Inc.
9.9% owner
2006-11-13 12:16:19500,000
0
500,000Form 13G
SUZUKI JOJI
Sr. V.P., Finance & Admin.
2006-01-06 21:51:09300,000
0
300,000Form 4
IWAKI YUICHI
President and CEO
2024-01-11 16:51:33210,000
0
210,000Form 4
ANDERSON BRIAN
Ex. VP-Corporate Development
2005-01-28 21:39:17200,000
0
200,000Form 3
Matsuda Kazuko
Chief Medical Officer
2024-01-11 16:52:04157,500
0
157,500Form 4
Lotz Mark W
V.P., Regulatory Affairs
2005-01-28 21:42:58120,000
0
120,000Form 3
OBrien Geoffrey
Vice President
2024-01-11 16:52:3584,000
0
84,000Form 4
Kalafer Michael E
Chief Medical Officer
2009-07-30 17:26:3945,277
31,744
77,021Form 4
GAMMANS RICHARD E SR
Chief Development Officer
2009-02-03 14:30:0160,000
0
60,000Form 4
Shigeta Hiroaki
Director
2012-05-15 16:02:1145,000
0
45,000Form 4
PRENDERGAST JOHN K A
Director
2011-07-20 21:18:5044,000
0
44,000Form 4
Johnson Kirk William
Chief Scientific Officer
2013-05-15 19:14:5842,500
0
42,500Form 4
COFFEE MICHAEL DENIS
Chief Business Officer
2013-05-15 19:16:3042,500
0
42,500Form 4
Locke Kenneth W
Chief Scientific Officer
2008-01-09 12:41:5939,000
0
39,000Form 4
Morris Arlene
Director
2013-05-23 12:13:1236,200
0
36,200Form 4
Asako Shintaro
Chief Financial Officer
2010-02-02 16:02:1535,700
0
35,700Form 4
Gaeta Federico C.A.
Chief Scientific Officer
2021-04-26 20:25:1624,000
0
24,000Form 4
Nagao Hideki
Director
2024-06-12 19:41:3320,000
0
20,000Form 4
Lemerond Nicole
Director
2024-06-12 19:40:3620,000
0
20,000Form 4
BEAVER CAROLYN
Director
2024-06-12 19:40:0920,000
0
20,000Form 4
Kobayashi Yutaka
Director
2020-06-17 18:37:3220,000
0
20,000Form 4
Ishizaka Yoshio
Director
2019-06-11 17:03:0420,000
0
20,000Form 4
van den Boom Esther
Chief Financial Officer
2014-08-08 16:38:2610,000
0
10,000Form 4
O'Toole David D
Director
2012-05-30 17:09:495,000
0
5,000Form 4
DUNTON ALAN W
Director
2010-06-15 16:51:250
1000
1000Form 4
Himawan Jeff
Director
2011-06-28 13:36:530
1000
1000Form 4
VAPNEK DANIEL
Director
2008-06-10 20:34:451000
0
1000Form 4
Stepanow Edward C Jr.
Chief Financial Officer
2020-06-24 16:42:170
0
0Form 3
Paulin Douglas
Chief Financial Officer
2021-08-10 16:02:220
0
0Form 3
Kruger Jason J
Chief Financial Officer
2022-06-27 18:36:190
0
0Form 3
Reyes Carla
Chief Financial Officer
2018-06-05 16:23:410
0
0Form 3
Selhorn Ryan J
Chief Financial Officer
2016-03-31 15:24:460
0
0Form 3
Gennaro Michael J
Chief Financial Officer
2011-09-19 08:53:380
0
0Form 3